Efficacy and safety of lixisenatide in the treatment of T2D

This article reviews clinical data for lixisenatide to date, both as monotherapy and in combination with basal insulin, and discusses the implications of lixisenatide for the management of T2DM (Expert Review of Endocrinology & Metabolism)